‘Manon Lescaut’ best Puccini in years

Anyone who saw Sunday afternoon’s revival of “Manon Lescaut” at the War Memorial is likely still burbling about the performance of Karita Mattila in the title role. The Finnish beauty with the silvery soprano is as good an actress as Cherry Jones.

Yet Mattila shouldn’t have been a surprise to anyone who has followed her dramatic career at San Francisco Opera, or as an enchanting recitalist who is apt to kick off her shoes to sing gypsy songs.

The surprise was not that Mattila sang and acted the spots off the country bumpkin who parlays her good looks into love and wealth, only to lose it all because of greed, but that the rest of the production and performance was up to her level, making this the best Puccini we’ve had in at least a decade of dreary “Butterflies.”

The problem with “Manon Lescaut” is that, despite its title, it is the tenor’s opera. Long, hard, high and nearly impossible to sing against the composer’s youthfully thunderous orchestration, Des Grieux also has to be handsome, sexy, passionate.

I’ve never seen a perfect Des Grieux, though I’ve heard a few who came close, and I would not have believed Misha Didyk could do it, but he did. First of all, he was tireless, still belting those high notes in the last act, even over conductor Donald Runnicles’ wide-open reading.

Secondly, he offered at least a modicum of the honeyed, seductive tones one expects from a French Chevalier. The duets, with Mattila as a fully involved partner, reached their passionate peak and beyond. And make no mistake, this is the most thrilling love music in all Puccini.

If it had been just those two, Runnicles and Puccini, it would have been enough, but almost everything worked. Adler Fellows Sean Panikkar (Edmondo) and Kendall Gladen (madrigal singer) lighted up their small roles.

John Hancock (Lescaut) and Eric Halfvarson (Geronte) seemed to be right off the stage of the Comedie Francaise. Director Olivier Tambosi created naturalistic stage pictures and telling detail. Ian Robertson’s chorus was a prominent protagonist.

And, except for a cramped third act set that kept the ensemble from soaring, Frank Philipp Schlossmann’s realistic designs were a delight.

How sensible not to set an 18th century opera in a storm drain on 2080 Mars.

Opera review

Manon Lescaut ????

Presented by San Francisco Opera

WHEN: Through Dec. 10

WHERE: 301 Van Ness Ave., San Francisco

PRICE: $30 to $245

INFO: (415) 864-3330 or www.sfopera.com

artsentertainmentOther Arts

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Dr. Vincent Matthews, superintendent of the San Francisco Unified School District, on Monday said “We truly wish we could return to in-person learning for everyone.” (Kevin N. Hume/S.F. Examiner)
SFUSD reopening plans still leave out most secondary students

SFUSD announces April return to in-person learning after reaching contract deal with teachers

(Examiner file photo)
Charter amendment effort would replace elected school board with appointed body

Critics of the San Francisco Unified School District board on Monday formally… Continue reading

Jill Bonny, owner of Studio Kazoku tattoo parlor in the Haight, tattoos client Lam Vo on Friday, March 5, 2021. (Kevin N. Hume/S.F. Examiner)
No one was fighting for tattoo artists, so they started advocating for themselves

Jill Bonny has been tattooing in the Bay Area since 2000. Four… Continue reading

The COVID-19 pandemic has prompted changes to The City's streets including Slow Streets closures to increase open space access and the Shared Spaces program, which allows businesses to use public right-of-ways for dining, retail and services. (Examiner illustration)
COVID is reshaping the streets of San Francisco

Walk down Page Street, which is closed to thru-traffic, and you might… Continue reading

(Go Nakamura/Getty Images/TNS)
Fully vaccinated? Here are the CDC guidelines for what you can do after receiving a COVID vaccine

The U.S. Centers for Disease Control and Prevention on Monday issued its… Continue reading

Most Read